Navigation Links
Medpace Hires Clinical Pharmacologist, Jim Wei, MD, PhD
Date:1/31/2008

CINCINNATI, Jan. 31 /PRNewswire/ -- Medpace, a leading global full-service contract research organization, announced it has hired Jim Wei, MD, PhD, as Director of Clinical Pharmacology.

Dr. Wei joins Medpace with extensive experience in the clinical trial regulatory aspects of early phase cardio-metabolic studies. He will consult with sponsors on their clinical trial programs and provide recommendations as to which studies merit inclusion in the programs and how the studies should be designed and analyzed.

Dr. Wei comes to Medpace from the FDA where he served as a Senior Reviewer in the Office of Clinical Pharmacology for almost 10 years. He was heavily involved in reviewing NDAs and INDs for the Division of Metabolism and Endocrinology Products. He was an active member of both the Drug Metabolism/Drug Interaction and Pharmacogenetics/Pharmacogenomics Working Groups. Previous to his work at the FDA, he was an Intramural Research Training Award (IRTA) Fellow at the Laboratory of Metabolism at the National Cancer Institute, a Fellow in the Clinical Pharmacology Section at the Veteran Affairs Medical Center in Boise, Idaho, and a staff physician in the Division of Cardiology and Clinical Pharmacology at the Zhejiang Medical University Hospital in China.

Dr. Wei received his medical degree from the Zhejiang Medical University and his PhD from the College of Pharmacy at Idaho State University. He is certified by the American Board of Clinical Pharmacology and is a member of the American Society of Clinical Pharmacology and Therapeutics. He was a previous member of the International Society of Study of Xenobiotics. Dr. Wei has presented many topics on drug metabolism/drug interaction, pharmacogenetics, and risk assessment in drug development at regional, national, and international conferences. He has published more than 20 peer reviewed articles and book chapters.

"We are excited to have an experienced clinical pharmacologist with exten
'/>"/>

SOURCE Medpace, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medpace Strengthens Presence in Central Europe
2. Third Security, LLC Hires Two New Managing Directors
3. Proteon Therapeutics Completes $12 Million Financing and Hires CFO
4. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
5. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
6. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
7. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
8. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
9. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
10. Biomoda Hires Manzano Strategies LLC to Spearhead Government Affairs Efforts
11. MedImmune Announces Seven Key Promotions and New Hires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... is rarely simple. From crop yields to disease risks, ... those considered "complex traits." Just as for heightthe textbook ... particular human disease are shaped by multiple genetic and ... involved. To track down such genes, geneticists typically mate ... large mouse and a small mouseand then study their ...
(Date:9/19/2014)... than electricity, to move data would consume much ... growing concern as chips, transistor counts rise. , ... light emitters, modulators, and detectors emitters ... source for optical chips is molybdenum disulfide (MoS2), ... a single, atom-thick layer. Other experimental on-chip light ...
(Date:9/19/2014)... NEW YORK , Sept. 19, 2014  An ... common forms of inherited neuropathies – Charcot-Marie-Tooth disease (CMT) ... feet and legs, causing extreme muscle atrophy, weakness, and ... in the US and millions worldwide. CMT is a ... use of their legs, requiring mobility devices such as ...
(Date:9/19/2014)... SAN FRANCISCO , Sept. 19, 2014 /PRNewswire/ ... announced results from preclinical studies characterizing the analgesic ... oral, peripherally-acting kappa opioid receptor agonist molecules. The ... molecule polymer medicinal chemistry platform. The ... described in the medical literature. 1,2 Kappa ...
Breaking Biology Technology:Want to link genes to complex traits? Start with more diversity 2Toward optical chips 2Toward optical chips 3September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5
... , , , , Efficiency of the standard protocols (1,2) ... (3) , , Propagate M13 ... For producing M13 ssDNA, mix 2.5 ml plating bacteria ... at 4 C for no more than 3 days) , ...
... , , , , Introduction ... , , , , , ... is an important part of your application. Many variables must be considered, , ... evaporation, and accessory chiller—so it's no surprise to find more , ...
... , To ensure that maximum transfection rates are achieved, the electroporation , ... , below for determining the ideal electroporation parameters as simply and , ... , Brochure available upon request., , , ... Field strength , ...
Cached Biology Technology:M13/Phagemid DNA Extraction Protocol 2Optimizing Büchi® Rotary Evaporator Applications 2Optimizing Büchi® Rotary Evaporator Applications 3Optimizing Büchi® Rotary Evaporator Applications 4Optimizing Büchi® Rotary Evaporator Applications 5Optimizing Büchi® Rotary Evaporator Applications 6Optimizing Büchi® Rotary Evaporator Applications 7Optimizing Büchi® Rotary Evaporator Applications 8
(Date:9/21/2014)... Contrary to what was previously thought, newborn immune T ... response to bacteria, according to a new study led ... very differently to that of adults, babies may still ... the study published in the journal Nature Medicine ... several different types of immune cells, including neutrophils which ...
(Date:9/19/2014)... researchers from several Harvard University labs in collaboration ... aspiring researchers with the intellectual raw materials needed ... soft, flexible materials. , With the advent of ... in manufacturing technology, soft robotics is emerging as ... conventional rigid robot design, but working with pliable ...
(Date:9/19/2014)... of years has adapted to the arctic cold, and then ... dangerous for you. , This is happening to the small ... substance, called nonylphenol, comes from the use of certain detergents, ... endocrine disruptor, but when entering the worm it has another ... cells in its body from cold damage. , Enchytraeus ...
Breaking Biology News(10 mins):Immune system of newborn babies is stronger than previously thought 2Soft robotics 'toolkit' features everything a robot-maker needs 2Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3
... researchers at Kansas State,University, with collaboration from Epitopix ... against E. coli O157 in beef ... focus on the post-harvest food safety,aspect, whether it,s ... Thomson of,K-State,s College of Veterinary Medicine. Thomson is ...
... health research by providing a goldmine of stored human biological ... we make better use of these invaluable resources by collaborating ... theme of an international conference being held in March 2009. ... use of biobanks through harmonization? The conference ...
... at the Johns Hopkins Bloomberg School of Public Health ... that triggers an immune response in multiple mosquito species ... -the parasite that causes malaria in humans. By ... block the development of the malaria-causing parasite in ...
Cached Biology News:K-State researchers help Epitopix license the United States' first E. coli O157 vaccine for cattle 2Harmonizing biobank research: An achievable world-wide goal 2Malaria immunity trigger found for multiple mosquito species 2